Merck Tbk. vs Nippon Indosari Corpindo Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Nippon Indosari Corpindo Tbk. trades at Rp610 (market cap 3.74T, 353.4K 24h volume). The key difference: Nippon Indosari Corpindo Tbk. is far larger — about 2.2× Merck Tbk.'s market cap, and Nippon Indosari Corpindo Tbk. is more actively traded (353.4K versus 37.6K). Which is the better fit depends on your goals.
| MERK | ROTI | |
|---|---|---|
Market Cap | 1.7T | 3.74T |
Volume | 37.6K | 353.4K |
Lot | 376 | 3.53K |
Turnover | 144.47M | 216.64M |
Average Price | 3,842.23 | 613.02 |
Value | 144.47M | 216.64M |
Indicative Equilibrium Price | 3,840 | 610 |
Indicative Equilibrium Volume | 7 | 95 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Nippon Indosari Corpindo (the company) was established under its original name of PT Nippon Indosari Corporation base on notarial deed No.11 of Benny Kristianto, S.H, dated on Mar 8, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 71 of Isbandi, S.H., dated Feb 24, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on ROTI →